Absonutrix, LLC – Trademark Portfolio
Entity Type: 16
Absonutrix, LLC owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ABCOCID, ABSONUTRIX, LYFETRITION, CRIUS COSMETICS, and AMERICAN SHAVING CO.. Of these, 6 are registered and 2 are pending. The portfolio spans 3 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 5 (Pharmaceuticals). Headquartered in Greensboro, NC.
Suite 206
5500 Adams Farm Lane
Greensboro, NC 27407
Showing of trademarks Trademarks
Trademark Classifications
Absonutrix, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Absonutrix, LLC have?
Absonutrix, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 1 abandoned.
What trademark classes does Absonutrix, LLC file in?
Absonutrix, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Absonutrix, LLC's most well-known trademarks?
Absonutrix, LLC's registered trademark portfolio includes well-known marks such as ABCOCID, ABSONUTRIX, LYFETRITION, CRIUS COSMETICS, and AMERICAN SHAVING CO.. These are among 6 currently registered trademarks in the portfolio.
What is Absonutrix, LLC's trademark registration success rate?
Absonutrix, LLC has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 2 applications are pending review.